[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,868
Citations 0
News From the Food and Drug Administration
June 5, 2018

Electrical Stimulation for Epilepsy

JAMA. 2018;319(21):2164. doi:10.1001/jama.2018.7068

A deep brain stimulation (DBS) system has received approval as an adjunct treatment to reduce seizures in certain patients with epilepsy.

The Medtronic DBS System for Epilepsy is indicated for adults who have partial onset seizures with or without secondary generalization and have not responded to 3 or more antiepileptic medications. The system is for patients who averaged 6 or more seizures per month during the previous 3 months, with no more than 30 days between seizures. It hasn’t been evaluated in patients whose seizures are less frequent.